PFA confirmation on Non Applicability of the criteria specified under SEBI Circular No. SEBI/HO/DDHS/P/CIR/2021/613 dated August 10, 2021 read with the SEBI/HO/DDHS/DDHS-RACPOD1/P/CIR/2023/172 ....
Awaiting price reaction for this filing.
MPS Pharmaa Limited (formerly Advik Laboratories Ltd) has submitted a confirmation to BSE stating that the company does not fall under the 'Large Corporate (LC)' category as of March 31, 2026, as per the SEBI framework for fund raising via debt securities. This means the company is exempt from the mandatory quarterly disclosures and borrowing requirements that apply to Large Corporates. The filing also reflects the company's recent name change from Advik Laboratories Limited to MPS Pharmaa Limited. BSE Scrip Code is 531686.
This is a routine compliance filing with no material impact on shareholders or stock price. It simply confirms the company is small enough by SEBI's criteria to be exempt from large corporate debt disclosure norms, and flags the name change from Advik Laboratories to MPS Pharmaa.